Literature DB >> 26859208

Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.

Amarnath Jena1, Sangeeta Taneja, Aashish Gambhir, Anil Kumar Mishra, Maria Mathew Dʼsouza, Sapna Manocha Verma, Puja Panwar Hazari, Pradeep Negi, Ganesh Krishna Rao Jhadav, Shanti Kumar Sogani.   

Abstract

PURPOSE: This study aimed to investigate the potential of hybrid gadolinium (Gd)-enhanced F-fluoroethyl-L-tyrosine (F-FET) PET/MRI in distinguishing recurrence from radiation necrosis using simultaneously acquired multiple structural and functional parameters.
METHODS: Twenty-six patients (5 female and 21 male patients; mean ± SD age, 51.58 ± 15.97 years) with single or multiple contrast-enhancing brain lesions (n = 32) on MRI after surgery and radiation therapy were evaluated with simultaneously acquired Gd-enhanced F-FET PET/MRI. They were then followed up with resurgery and histopathological diagnosis (n = 9) and/or clinical/MRI- or PET/MRI-based imaging follow-up (n = 17). PET/MR images were analyzed using manually drawn regions of interest over areas of maximal contrast enhancement and/or FET uptake. Maximum target-to-background ratio (TBRmax), mean target-to-background ratio (TBRmean), and choline-to-creatine (Cho/Cr) ratios as well as normalized mean relative cerebral blood volume (rCBVmean) and mean apparent diffusion coefficient (ADCmean) were determined. The accuracy of each parameter individually and in various possible combinations for differentiating recurrence versus radiation necrosis was evaluated using 2-tailed independent samples Student t test, multivariate analysis of variance, and multivariate receiver operating characteristic analysis. Positive histopathological finding and long-term imaging/clinical follow-up suggestive of disease progression served as criterion standard.
RESULTS: Of 26 patients, 19 were classified as recurrence, with 7 patients showing radiation necrosis. Individually, TBRmax, TBRmean, ADCmean, and Cho/Cr ratios as well as normalized rCBVmean was significant in differentiating recurrence from radiation necrosis, with an accuracy of 93.8% for TBRmax, 87.5% for TBRmean, 81.3% for ADCmean, 96.9% for Cho/Cr ratio, and 90.6% for normalized rCBVmean. The accuracy of both normalized rCBVmean and ADCmean was improved in combination with TBRmax or Cho/Cr ratio. However, TBRmax (or TBRmean) with Cho/Cr ratio yielded the highest accuracy, approaching up to 97%. Furthermore, maximum area under the curve is achieved with the combination of TBRmean, CBV, and Cho/Cr values.
CONCLUSIONS: Our findings suggest that FET uptake with Cho/Cr ratio and normalized rCBVmean could be most useful to distinguish primary glioma recurrence from radiation necrosis. Hybrid simultaneous multiparametric F-FET PET/MRI might play a significant role in the evaluation of patients with suspected glioma recurrence.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26859208     DOI: 10.1097/RLU.0000000000001152

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  21 in total

1.  Post-gadolinium 3-dimensional spatial, surface, and structural characteristics of glioblastomas differentiate pseudoprogression from true tumor progression.

Authors:  Madison R Hansen; Edward Pan; Andrew Wilson; Morgan McCreary; Yeqi Wang; Thomas Stanley; Marco C Pinho; Xiaohu Guo; Darin T Okuda
Journal:  J Neurooncol       Date:  2018-06-07       Impact factor: 4.130

2.  In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.

Authors:  Julie Bolcaen; Benedicte Descamps; Marjan Acou; Karel Deblaere; Caroline Van den Broecke; Tom Boterberg; Christian Vanhove; Ingeborg Goethals
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

3.  Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.

Authors:  Derek Richard Johnson; Chad Allan Glenn; Ramin Javan; Jeffrey James Olson
Journal:  J Neurooncol       Date:  2021-10-25       Impact factor: 4.130

4.  Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [18F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma.

Authors:  Otto M Henriksen; Adam E Hansen; Aida Muhic; Lisbeth Marner; Karine Madsen; Søren Møller; Benedikte Hasselbalch; Michael J Lundemann; David Scheie; Jane Skjøth-Rasmussen; Hans S Poulsen; Vibeke A Larsen; Henrik B W Larsson; Ian Law
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-30       Impact factor: 10.057

Review 5.  Diagnostic Performance of PET and Perfusion-Weighted Imaging in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature.

Authors:  N Soni; M Ora; N Mohindra; Y Menda; G Bathla
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-27       Impact factor: 3.825

Review 6.  Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective.

Authors:  Lisbeth Marner; Otto M Henriksen; Michael Lundemann; Vibeke Andrée Larsen; Ian Law
Journal:  Clin Transl Imaging       Date:  2016-11-18

Review 7.  Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients.

Authors:  Philipp Lohmann; Jan-Michael Werner; N Jon Shah; Gereon R Fink; Karl-Josef Langen; Norbert Galldiks
Journal:  Cancers (Basel)       Date:  2019-01-29       Impact factor: 6.639

8.  Quantitative biparametric analysis of hybrid 18F-FET PET/MR-neuroimaging for differentiation between treatment response and recurrent glioma.

Authors:  Johannes Lohmeier; Georg Bohner; Eberhard Siebert; Winfried Brenner; Bernd Hamm; Marcus R Makowski
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

9.  Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review.

Authors:  Motomasa Furuse; Naosuke Nonoguchi; Kei Yamada; Tohru Shiga; Jean-Damien Combes; Naokado Ikeda; Shinji Kawabata; Toshihiko Kuroiwa; Shin-Ichi Miyatake
Journal:  Radiat Oncol       Date:  2019-02-06       Impact factor: 3.481

10.  Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes.

Authors:  Eike Steidl; Karl-Josef Langen; Sarah Abu Hmeidan; Nenad Polomac; Christian P Filss; Norbert Galldiks; Philipp Lohmann; Fee Keil; Katharina Filipski; Felix M Mottaghy; Nadim Jon Shah; Joachim P Steinbach; Elke Hattingen; Gabriele D Maurer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-26       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.